Neuroene Therapeutics Inc

Biotechnology company · Washington, District of Columbia, United States

Neuroene Therapeutics Inc is a biotechnology company headquartered in Washington, District of Columbia, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $2.4 million in total, most recently in 2023.

www.neuroenetherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Neuroene Therapeutics at a glance

Typebiotechnology company

HeadquartersWashington, District of Columbia, United States

Employees (self-reported, 2023)5

What does Neuroene Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $2.4 million in total (2016 to 2023). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Institute of Allergy and Infectious Diseases.

Frequently asked questions about Neuroene Therapeutics

Where is Neuroene Therapeutics headquartered?

Neuroene Therapeutics Inc is headquartered in Washington, District of Columbia, United States.

What does Neuroene Therapeutics do?

Neuroene Therapeutics Inc is a biotechnology company.

Similar companies

Vitakey Inc.Washington, District of Columbia, United States
Floreo, Inc.Washington, District of Columbia, United States
OncovirWashington, District of Columbia, United States
Nanochon, Inc.Washington, District of Columbia, United States
Media Rez LLCWashington, District of Columbia, United States
Amelia Technologies LLCWashington, District of Columbia, United States
Cyrano Therapeutics, Inc.Washington, District of Columbia, United States
Openbeds Inc.Washington, District of Columbia, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences